Work

Author response for "ER+, HER2– advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes"

Year: 2023

Type: peer-review

Source: Publons reviews and discussion

DOI: 10.1002/1878-0261.13416/v2/response1

Authors: Jessica W. Chen, William Jacot, Javier Cortés, Ian E. Krop, Susan Dent, Nadia Harbeck, Michelino De Laurentiis, Véronique Diéras, Young‐Hyuck Im, Thomas J. Stout, Frauke Schimmoller, Heidi M. Savage, Katherine E. Hutchinson, Timothy R. Wilson

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4324054644

Cites:

Cited by:

Related to: 10